Endothelial progenitor cells and chronic obstructive pulmonary disease: From basic research to clinical application
Xue He1,2, Huihui Zeng3,4,5,6, Yan Chen7,8,9,10
1Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. hexuehuxi@csu.edu.cn.
Endothelial progenitor cells (EPCs) are crucial for vascular repair in chronic obstructive pulmonary disease (COPD). Reduced EPCs in COPD patients correlate with disease severity, and environmental factors further impair EPC function, suggesting EPCs as a therapeutic target.
Area of Science:
- Pulmonary Medicine
- Vascular Biology
- Regenerative Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) involves persistent airflow limitation and vascular endothelial dysfunction.
- Endothelial progenitor cells (EPCs) are vital for vascular repair and regeneration, playing a key role in COPD pathogenesis.
Purpose of the Study:
- To investigate the role of EPCs in COPD pathogenesis.
- To explore the impact of environmental factors on EPCs in COPD.
- To evaluate EPCs as a potential therapeutic target for COPD.
Main Methods:
- Analysis of circulating EPC number and function in COPD patients.
- Assessment of environmental factors (smoking, PM2.5) on EPCs.
- Review of molecular pathways (VEGF/VEGFR, CXCL12/CXCR4) regulating EPCs.
- Examination of EPC transplantation efficacy in animal models.
Main Results:
- COPD patients exhibit significantly reduced numbers and impaired function of circulating EPCs.
- EPC reduction is associated with COPD severity, lung function decline, exacerbations, and comorbidities.
- Environmental factors like smoking and PM2.5 further diminish EPC quantity and function.
- Animal studies demonstrate improved lung function and pathology after EPC transplantation.
Conclusions:
- EPC dysfunction is a key pathogenic mechanism in COPD.
- Targeting EPCs holds promise as a novel therapeutic strategy for COPD.
- Further research into EPC mechanisms and clinical applications may advance COPD treatment.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation


